SomnoMed Company Description
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.
It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea.
The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances.
In addition, it provides Sunrise, a bio-signal to diagnose sleep apnea. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Country | Australia |
Founded | 1987 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 300 |
Contact Details
Address: 20 Clarke Street Crows Nest, 2065 Australia | |
Phone | 61 2 9467 0400 |
Website | somnomed.com |
Stock Details
Ticker Symbol | SOMNF |
Exchange | OTCMKTS |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000SOM1 |
SIC Code | 3843 |
Key Executives
Name | Position |
---|---|
Karen Borg B.A. | Co-Chief Executive Officer and Executive Director |
Amrita Blickstead BME, M.B.A. | Co-Chief Executive Officer and Executive Director |
Mark Harding | Senior Vice President of Global Marketing |
Matthew Conlon | Executive Vice President of Sales and Marketing - North America |
Marco Van Kleef | Vice President of Marketing and Sales - Europe |
Ye-Fei Guo | Chief Financial Officer |
Terence A. Flitcroft B.Com., B.Comm., C.A., SF FIN | Company Secretary |
Christopher Bedford | Vice President of Global Production and Product Development |